Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1992-1-9
pubmed:abstractText
In a Danish population-based non-Hodgkin lymphoma (NHL) registry, 1257 newly diagnosed NHL cases were registered over a 5-year period. Of these, 463 (37%) were extranodal. The gastrointestinal tract was the most common site of extranodal involvement (30% of the cases). Histologically, 44% of all extranodal NHL cases had high-grade, 17% intermediate and 27% low-grade features, while 12% were unclassified. The most common histological subtype (Kiel) was the centroblastic diffuse (23% of cases). 50% of all extranodal NHL were localised (stage IE or IIE) and 27% had B symptoms. Site-specific features included a strong age-correlation for thyroid and testes lymphoma (greater than 50 years) and a high prevalence of female cases in thyroid and salivary glands lymphomas (M/F 0.14 and 0.30, respectively). Overall 7-year survival for extranodal NHL was 46% (median 4.9 years). Poor prognosis patients could be identified by the presence of one or more of the following presentation characteristics: age greater than 65 years, B symptoms, high-grade histology, disseminated disease, elevated s-IgA and hyperuricaemia. Relative risk values ranged from 2.1 for age and B symptoms to 1.7 for hyperuricaemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0959-8049
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1201-8
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:1835586-Adolescent, pubmed-meshheading:1835586-Adult, pubmed-meshheading:1835586-Age Factors, pubmed-meshheading:1835586-Aged, pubmed-meshheading:1835586-Aged, 80 and over, pubmed-meshheading:1835586-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:1835586-Child, pubmed-meshheading:1835586-Child, Preschool, pubmed-meshheading:1835586-Cyclophosphamide, pubmed-meshheading:1835586-Doxorubicin, pubmed-meshheading:1835586-Female, pubmed-meshheading:1835586-Humans, pubmed-meshheading:1835586-Lymph Nodes, pubmed-meshheading:1835586-Lymphoma, Non-Hodgkin, pubmed-meshheading:1835586-Male, pubmed-meshheading:1835586-Middle Aged, pubmed-meshheading:1835586-Neoplasm Staging, pubmed-meshheading:1835586-Prednisone, pubmed-meshheading:1835586-Prognosis, pubmed-meshheading:1835586-Risk Factors, pubmed-meshheading:1835586-Sex Factors, pubmed-meshheading:1835586-Vincristine
pubmed:year
1991
pubmed:articleTitle
Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group.
pubmed:affiliation
Department of Haematology, Odense University Hospital, Denmark.
pubmed:publicationType
Journal Article